<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=217082&amp;fmt=gif">

Clinical Diagnostics

Molecular Analytics

Comprehensive Evaluation of Nucleic Acids

Full suite of molecular capabilities for analysis of nucleic acids

MD Biosciences offers a diverse array of molecular capabilities for analysis of genetic, genomic and epigenetic components of disease. From longitudinal analysis of liquid biopsies to nucleic acid testing of pathogenic organisms, our accomplished molecular biologists can provide you with optimal solutions to meet your complex molecular analysis requirements.

We offer standardized, validated assays in numerous therapeutic areas, as well as custom assay solutions (including assay validation) for discovery, preclinical and clinical-phase evaluations.

Our molecular capabilities include:

  • Nucleic acid extractions from multiple sample types (fresh, frozen & FFPE tissues, liquid biopsies, disaggregated tumor samples, etc)
  • High-sensitivity real-time qPCR for DNA and RNA Analysis
  • Single gene and array-based mRNA/miRNA expression profiling
  • Gene sequence analysis
  • Epigenetic analyses such as promotor methylation
  • Genotyping services
  • Pharmacogenomic testing 
  • Custom assay design and validation


Request More Information





+41-44-986 2628

Email Us

Clinical Diagnostic Services

  • ELISA Protein Analysis,
  • Western Blot
  • Multiplexed Protein Analysis
  • Flow Cytometry
  • Serology
  • Real time qPCR
  • Multiplexed mRNA analysis
  • Multiplexed miRNA analysis
  • Tissue Extraction
  • Assay Development
  • Urinalysis
  • Hematology
  • Clinical chemistry
  • Capabilities to work with all biofluids and stool samples